Michael Henrickson

A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

Nicolino Ruperto, Daniel J. Lovell, Rubén Cuttica et al. · Arthritis & Rheumatism · 2007 · 411 citations

Medicine, Pediatrics, Pharmacotherapy +12

The Tumor-Necrosis-Factor Receptor–Associated Periodic Syndrome: New Mutations in TNFRSF1A, Ancestral Origins, Genotype-Phenotype Studies, and Evidence for Further Genetic Heterogeneity of Periodic Fevers

Ivona Aksentijevich, Jérôme Galon, Miguel Luz Soares et al. · The American Journal of Human Genetics · 2001 · 338 citations · Full text

Life Sciences, Immunology, Molecular Genetics +17

Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus

Rina Mina, Emily von Scheven, Stacy P. Ardoin et al. · Arthritis Care & Research · 2011 · 194 citations · Full text

Medicine, Nephrology, Pediatrics +14

Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

Hermine I. Brunner, Carlos Abud‐Mendoza, Diego Oscar Viola et al. · Annals of the Rheumatic Diseases · 2020 · 193 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Loss- or Gain-of-Function Mutations in ACOX1 Cause Axonal Loss via Different Mechanisms

Hyung-Lok Chung, Michael F. Wangler, Paul C. Marcogliese et al. · Neuron · 2020 · 163 citations · Full text

Life Sciences, Genetics, Neuroscience +8